Free Trial

TD Asset Management Inc Has $53.55 Million Stock Position in Teleflex Incorporated $TFX

Teleflex logo with Medical background

Key Points

  • TD Asset Management Inc has reduced its stake in Teleflex Incorporated by 7.7% during the second quarter, now holding approximately 1.02% of the company with a value of $53.55 million.
  • Teleflex recently reported quarterly earnings of $3.73 per share, exceeding analysts' expectations, with revenues totaling $780.9 million, an increase of 4.2% year-over-year.
  • The company has announced a quarterly dividend of $0.34 per share, reflecting a 1.1% yield with a payout ratio of 32%.
  • MarketBeat previews the top five stocks to own by November 1st.

TD Asset Management Inc lessened its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 7.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 452,400 shares of the medical technology company's stock after selling 37,600 shares during the period. TD Asset Management Inc owned approximately 1.02% of Teleflex worth $53,546,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in TFX. Thompson Investment Management Inc. grew its stake in shares of Teleflex by 2.1% during the second quarter. Thompson Investment Management Inc. now owns 4,970 shares of the medical technology company's stock worth $588,000 after buying an additional 100 shares during the last quarter. CX Institutional grew its stake in shares of Teleflex by 14.7% during the second quarter. CX Institutional now owns 872 shares of the medical technology company's stock worth $103,000 after buying an additional 112 shares during the last quarter. Signaturefd LLC grew its stake in shares of Teleflex by 38.3% during the first quarter. Signaturefd LLC now owns 433 shares of the medical technology company's stock worth $60,000 after buying an additional 120 shares during the last quarter. Empirical Finance LLC grew its stake in shares of Teleflex by 7.9% during the first quarter. Empirical Finance LLC now owns 1,690 shares of the medical technology company's stock worth $234,000 after buying an additional 124 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in Teleflex by 30.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company's stock worth $77,000 after buying an additional 129 shares during the period. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Performance

Shares of Teleflex stock opened at $121.66 on Thursday. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The business has a 50-day moving average price of $124.72 and a two-hundred day moving average price of $123.93. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $241.41. The company has a market cap of $5.38 billion, a P/E ratio of 28.63, a PEG ratio of 1.71 and a beta of 1.05.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The firm had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business's revenue was up 4.2% compared to the same quarter last year. During the same period last year, the business posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Friday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex's dividend payout ratio is currently 32.00%.

Insider Buying and Selling at Teleflex

In related news, Director Andrew A. Krakauer bought 1,000 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were acquired at an average cost of $115.25 per share, with a total value of $115,250.00. Following the completion of the purchase, the director directly owned 7,192 shares in the company, valued at $828,878. The trade was a 16.15% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jaewon Ryu bought 1,500 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the completion of the purchase, the director owned 3,727 shares of the company's stock, valued at $428,605. This represents a 67.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 5,500 shares of company stock valued at $633,590 over the last 90 days. Insiders own 1.40% of the company's stock.

Analysts Set New Price Targets

TFX has been the topic of several recent research reports. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Monday, September 15th. Mizuho lifted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Royal Bank Of Canada lifted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. Wells Fargo & Company cut their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Finally, Weiss Ratings reiterated a "sell (d+)" rating on shares of Teleflex in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Reduce" and an average price target of $141.57.

Read Our Latest Analysis on Teleflex

Teleflex Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.